Profitability
5.4%
1st of 2 listed peers · median of the other 1: 3.7%
Net margin 0.2% (FY26)
return on capital
5.4%3.7%
SARTHAK GLOBALNORRIS MEDICINES
Median of the other 1: 3.7%
BSE: SARTHAKGL · Services · Trading & Distributors · Market cap ₹14 Cr
· Prev close ₹45.40 · Volume 759
Company profile: not in our data yet
Net margin 0.2% (FY26)
Median of the other 1: 3.7%
Generated Return on capital is 5.4%, 1st of 2 listed peers.
Profit, last 4 quarters vs the 4 before: not in our data yet
Generated In FY26 revenue was −27.8% and net profit −64.7% on FY25.
P/E not shown: the EPS for the 4 quarters Sep 2025 to Jun 2026 is a loss
Of profit came in as cash, last 5 fiscal years: not in our data yet
100%: all profit arrived as cash
Generated Operating cash was positive in each of the two years FY25–26; FY26 alone brought in ₹2 cr. Total debt was ₹10 cr at the end of FY26, against a net worth of ₹2 cr.
Held by domestic funds: not in our data yet
In 1 month: not in our data yet
Generated The close is above its 20 and 50-day averages of ₹40 and ₹39.
An earnings call transcript: not in our data yet
Scored statements from the earnings calls: none yet.
Earnings outlook Generated
In Q1 FY27 (Jun 26), net profit was −117.4% and revenue −89.8% on the year-earlier quarter; operating margin was −111.4% against 70.9%.
An earnings call transcript: not in our data yet